Aims-To elucidate the fine specificities of the antibodies MIB 1 and MIB 3 and of additional monoclonal antibodies which also recognise the Ki-67 protein (MIB 5, IND.64, First studies showed that the epitopes of MIB 1, MIB 3, and Ki-676 as well as that of MIB 5 (unpublished results) are located on an identical stretch of 20 amino acids within the Ki-67 protein. This sequence represents a part of the highly conserved 22 amino acid element called "Ki-67 motif'. In the Ki-67 protein it appears 16 times with a homology between 72% and 100% with regard to the amino acid sequence ( fig 1A) .'0 Because of the importance of estimating the Ki-67 growth fraction, the aim of our study was to elucidate the fine specificities of antibodies directed against the Ki-67 protein within the 22 amino acid sequence mentioned above, and to compare the epitopes recognised by the antibodies MIB 1, 3, 5, Ki-67, and JG-67-2all and the recently described monoclonal antibody IND.64,12 which represents an additional Ki-67 equivalent antibody.'3 Methods All amino acid sequences mentioned are written in the one letter code from the N-terminus to the C-terminus (from left to right).
The monoclonal antibody Ki-67 was found in 1983 after mouse myeloma cells had been fused with the spleen cells of mice immunised with nuclei of L 428 cell line cells.' Detailed cell cycle analysis showed that this antibody detects a nuclear antigen (Ki-67 protein) which is exclusively expressed in proliferating cells-that is, in Gl, S, G, phases, and mitosis, but not in Go.'
Because of these properties, Ki-67 has become a powerful tool during the past decade for estimating the growth fraction in malignant disease, based on numerous studies which have consistently shown that there is a highly significant correlation between the mean values of the growth fraction determined with the monoclonal antibody and the histopathological grade of malignancy. [3] [4] [5] The inherent drawback of Ki-67 is that it can be applied only to fresh material, and not routinely formalin fixed and paraffin wax embedded tissue-and, therefore, in retrospective studies of archival material. Recently, we produced new monoclonal antibodies using a recombinant partial structure of the Ki-67 protein as immunogen. These antibodies, designated MIB 1-3, represent true Ki-67 equivalents as determined by histochemistry and immunobiochemistry. 6 Two of these new antibodies (MIB 1 and MIB 3) as well as the antibody MIB 5 generated subsequently7 can detect the Ki-67 protein in routinely formalin fixed, paraffin wax embedded normal and tumour tissues when using an antigen retrieval method based on microwave treatment.89 Thus the new Ki-67 equivalent antibodies MIB 1, 3, and 5 now permit the detection of the Ki-67 protein on archival material.
First studies showed that the epitopes of MIB 1, MIB 3, and Ki-676 as well as that of MIB 5 (unpublished results) are located on an identical stretch of 20 amino acids within the Ki-67 protein. This sequence represents a part of the highly conserved 22 amino acid element called "Ki-67 motif'. In the Ki-67 protein it appears 16 times with a homology between 72% and 100% with regard to the amino acid sequence ( fig 1A) .'0 Because of the importance of estimating the Ki-67 growth fraction, the aim of our study was to elucidate the fine specificities of antibodies directed against the Ki-67 protein within the 22 amino acid sequence mentioned above, and to compare the epitopes recognised by the antibodies MIB 1, 3, 5, Ki-67, and JG-67-2all and the recently described monoclonal antibody IND.64,12 which represents an additional Ki-67 equivalent antibody.'3 Methods All amino acid sequences mentioned are written in the one letter code from the N-terminus to the C-terminus (from left to right).
Antibodies Plasmids of successfully transformed E coli clones were isolated using Qiagen Tip-100 columns (Diagen, Hilden, Germany).
Sequencing of purified plasmids was performed on an ALF DNA sequencer according to the manufacturer's recommendation (Pharmacia, Freiburg, Germany).
SDS-PAGE AND IMMUNOBLOTTING
Preparation of bacterial cell lysates for SDS-PAGE was performed as described.6 Lysates of bacteria were separated on reducing 7-5% separation gels with 3% stacking gels. Molecular weight markers were obtained from Sigma (Munich, Germany). Proteins were transferred to nitrocellulose membranes (BA 85, Schleicher & Schuell, Dassel, Germany) by western blot technique'6 in a Biometra (Gottingen, Germany) semi-dry blotting apparatus (two hours at 150 mA).
Unoccupied protein binding sites of the nitrocellulose were blocked by incubation for one hour with blocking solution (2% bovine serum albumin (BSA), 0 05% Triton X-100 in TRIS-buffered saline (TBS)). After one hour of incubation with primary antibody and thorough washing with TBS the bound antibody was targeted with goat anti-mouse alkaline phosphatase conjugate (Dianova, Hamburg, Germany), diluted 1 in 10 000 in blocking solution.
The phosphatase activity was visualised using nitro blue tetrazolium (NBT) and 5- (fig 3) . This result is well in line with those obtained with the recombinant fusion protein (fl-galactosidase/Epi 2) as described above (fig 2) .
IMMUNOREACTIVITY OF ANTIBODIES WITH BACTERIALLY EXPRESSED PEPTIDES DEDUCED FROM Kl-67 PROTEIN cDNA
To elucidate further the epitopes of the antibodies within the Epi 2 sequence, we constructed three plasmids which encode for three different fusion proteins. The fusion proteins consist of fl-galactosidase and one of three different but overlapping 10 Thus we assumed the seven amino acid sequence AGFKELF to be the region in which the epitopes of the antibodies are located, as this sequence appears in all constructions which lead to a positive reaction of the antibodies.
SPOT-BLOT
To localise the epitope within the sequence AGFKELF we synthesised six different overlapping heptapeptides ( fig 5A) exclude that the antibody MIB 2 recognises any sequence used in the SPOT-blot (see above), only those signals were regarded as positive which showed a stronger intensity than those obtained with the antibody MIB 2. 
